PTPI logo

Petros Pharmaceuticals (PTPI) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

02 December 2020

Indexes:

Not included

Description:

Petros Pharmaceuticals (PTPI) is a healthcare company focused on developing and marketing innovative treatments for men's health issues, particularly erectile dysfunction. They aim to improve patients' quality of life through effective therapies and are committed to advancing medical solutions in the pharmaceutical industry.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 15, 2021

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 01, 2022

Analyst ratings

Recent major analysts updates

08 Dec '23 Maxim Group
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment”
Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment”
Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment”
PTPI
accesswire.com19 December 2024

Company positions itself for new innovation utilizing AI and quantum computing to help expand patient access to drugs via OTC access NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announced that in a recent podcast, The Intelligent Leadership Podcast, titled, "The New Era of Healthcare, AI, Data and Consumer Empowerment," Petros President Fady Boctor discussed the Company's concerted efforts to develop its proprietary platform as a prospective technology driven Rx-to-OTC switch solution across a multitude of conditions and existing Rx only therapies. During the podcast, Boctor discussed Petros' technology tool development around a Drug Facts Label to self-select, as well as the utilization of AI to ensure safe engagement and access to a drug that has made the Rx-to-OTC switch.

Petros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Petros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Petros Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
PTPI
Accesswire06 September 2023

NEW YORK, NY / ACCESSWIRE / September 6, 2023 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI), a pioneer in expanding consumer access to medication through over the counter (OTC) pathways, announces today that Fady Boctor, President and Chief Commercial Officer, will present a corporate overview at the H.C. Wainwright 25th Annual Global Investment Conference.

FAQ

  • What is the primary business of Petros Pharmaceuticals?
  • What is the ticker symbol for Petros Pharmaceuticals?
  • Does Petros Pharmaceuticals pay dividends?
  • What sector is Petros Pharmaceuticals in?
  • What industry is Petros Pharmaceuticals in?
  • What country is Petros Pharmaceuticals based in?
  • When did Petros Pharmaceuticals go public?
  • Is Petros Pharmaceuticals in the S&P 500?
  • Is Petros Pharmaceuticals in the NASDAQ 100?
  • Is Petros Pharmaceuticals in the Dow Jones?
  • When was Petros Pharmaceuticals's last earnings report?
  • When does Petros Pharmaceuticals report earnings?
  • Should I buy Petros Pharmaceuticals stock now?

What is the primary business of Petros Pharmaceuticals?

Petros Pharmaceuticals (PTPI) is a healthcare company focused on developing and marketing innovative treatments for men's health issues, particularly erectile dysfunction. They aim to improve patients' quality of life through effective therapies and are committed to advancing medical solutions in the pharmaceutical industry.

What is the ticker symbol for Petros Pharmaceuticals?

The ticker symbol for Petros Pharmaceuticals is NASDAQ:PTPI

Does Petros Pharmaceuticals pay dividends?

No, Petros Pharmaceuticals does not pay dividends

What sector is Petros Pharmaceuticals in?

Petros Pharmaceuticals is in the Healthcare sector

What industry is Petros Pharmaceuticals in?

Petros Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is Petros Pharmaceuticals based in?

Petros Pharmaceuticals is headquartered in United States

When did Petros Pharmaceuticals go public?

Petros Pharmaceuticals's initial public offering (IPO) was on 02 December 2020

Is Petros Pharmaceuticals in the S&P 500?

No, Petros Pharmaceuticals is not included in the S&P 500 index

Is Petros Pharmaceuticals in the NASDAQ 100?

No, Petros Pharmaceuticals is not included in the NASDAQ 100 index

Is Petros Pharmaceuticals in the Dow Jones?

No, Petros Pharmaceuticals is not included in the Dow Jones index

When was Petros Pharmaceuticals's last earnings report?

Petros Pharmaceuticals's most recent earnings report was on 15 November 2021

When does Petros Pharmaceuticals report earnings?

The date for Petros Pharmaceuticals's next earnings report has not been announced yet

Should I buy Petros Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions